Skip to main content
icon for Will Humana (HUM) beat quarterly earnings?
Заробіток·Приховати від нового

Will Humana (HUM) beat quarterly earnings?

icon for Will Humana (HUM) beat quarterly earnings?
Заробіток·Приховати від нового

Will Humana (HUM) beat quarterly earnings?

Ended: Jul 29

Ended: Jul 29

>99% шанс
Polymarket

$3,383 Обс.

>99% шанс
Polymarket

$3,383 Обс.

As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Trader sentiment for Humana beating Q2 2026 earnings sits at an even 50% implied probability ahead of the July 29 release, reflecting balanced views on Medicare Advantage medical loss ratios and potential star-rating recovery. Q1 results showed a solid beat at $10.31 versus $9.97 expected, yet analysts maintain a consensus Hold rating with price targets clustered near $311–$321, citing ongoing pressures in the managed-care sector. Recent upgrades from Deutsche Bank and Mizuho highlight stabilizing enrollment and bonus-payment upside, but consensus 2026 EPS estimates near $9.02 underscore caution on margin expansion. The closely contested market hinges on whether July trends in utilization and plan positioning confirm these improvements or reveal further headwinds.

As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.

If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.)

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Обсяг
$3,383
Дата завершення
Jul 29, 2026
Ринок відкрито
Jul 15, 2026, 8:49 PM ET

Джерело вирішення

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Результат запропоновано: Yes

Без оскарження

Кінцевий результат: Yes

As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS. Trader sentiment for Humana beating Q2 2026 earnings sits at an even 50% implied probability ahead of the July 29 release, reflecting balanced views on Medicare Advantage medical loss ratios and potential star-rating recovery. Q1 results showed a solid beat at $10.31 versus $9.97 expected, yet analysts maintain a consensus Hold rating with price targets clustered near $311–$321, citing ongoing pressures in the managed-care sector. Recent upgrades from Deutsche Bank and Mizuho highlight stabilizing enrollment and bonus-payment upside, but consensus 2026 EPS estimates near $9.02 underscore caution on margin expansion. The closely contested market hinges on whether July trends in utilization and plan positioning confirm these improvements or reveal further headwinds.

As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents.

If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.)

If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”

Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Обсяг
$3,383
Дата завершення
Jul 29, 2026
Ринок відкрито
Jul 15, 2026, 8:49 PM ET

Джерело вирішення

https://seekingalpha.com/

Resolver

0x65070BE91...
As of market creation, Humana is estimated to release earnings on July 29, 2026. The Street consensus estimate for Humana’s non-GAAP EPS for the relevant quarter is $7.00 as of market creation. This market will resolve to "Yes" if Humana reports non-GAAP EPS greater than $7.00 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Humana releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for non-GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Результат запропоновано: Yes

Без оскарження

Кінцевий результат: Yes

Пов'язане

icon for Will MetLife (MET) beat quarterly earnings?

Will MetLife (MET) beat quarterly earnings?

59%
icon for Will HubSpot (HUBS) beat quarterly earnings?

Will HubSpot (HUBS) beat quarterly earnings?

63%
icon for Will Chegg (CHGG) beat quarterly earnings?

Will Chegg (CHGG) beat quarterly earnings?

72%

Обережно з зовнішніми посиланнями.

Часті запитання

«Will Humana (HUM) beat quarterly earnings?» — це ринок прогнозів на Polymarket, де трейдери купують і продають акції «Так» або «Ні» залежно від того, чи вірять вони, що ця подія станеться. Поточна краудсорсингова ймовірність — 100% для «Yes». Наприклад, якщо «Так» коштує 100¢, ринок колективно оцінює шанс цієї події в 100%. Ці шанси безперервно змінюються, коли трейдери реагують на нові події. Акції правильного результату погашаються по $1 кожна при вирішенні ринку.

«Will Humana (HUM) beat quarterly earnings?» — це нещодавно створений ринок на Polymarket, запущений Jul 15, 2026. Як ранній ринок, це ваша можливість бути серед перших трейдерів, що встановлюють шанси. Ви також можете зберегти цю сторінку в закладки для відстеження обсягу.

Щоб торгувати на «Will Humana (HUM) beat quarterly earnings?», просто оберіть, чи вірите ви, що відповідь — «Так» або «Ні». Кожна сторона має поточну ціну, що відображає ймовірність ринку. Введіть суму та натисніть «Торгувати». Якщо ви купили акції «Так» і результат — «Так», кожна акція виплачує $1. Якщо «Ні» — ваші акції «Так» коштують $0. Ви також можете продати акції в будь-який час до вирішення.

Поточна ймовірність для «Will Humana (HUM) beat quarterly earnings?» — 100% для «Yes». Це означає, що спільнота Polymarket вважає, що є 100% шанс, що ця подія станеться. Ці шанси оновлюються в реальному часі.

Правила вирішення для «Will Humana (HUM) beat quarterly earnings?» точно визначають, що має статися для оголошення переможця — включаючи офіційні джерела даних. Ви можете переглянути повні критерії вирішення в розділі «Правила» на цій сторінці. Рекомендуємо уважно прочитати правила перед торгівлею.